Additionally, gut microbiota, epigenetic factors (microRNAs, histone modification and DNA methylation), mitochondrial dysfunction, immune responses and genetic factors (PNPLA3 and HSD17B13) contribute to NASH development and progression [23]. The gene discussed is HSD17B13; the disease is metabolic dysfunction-associated steatohepatitis.